The Effect of Low-Dose Furosemide in Critically Ill Patients With Early Acute Kidney Injury: A Pilot Randomized Blinded Controlled Trial (The SPARK Study)

Journal of Critical Care - Netherlands
doi 10.1016/j.jcrc.2017.07.030
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Outcome of Critically Ill Patients With Acute Kidney Injury Using the Acute Kidney Injury Network Criteria*

Critical Care Medicine
Critical CareIntensive Care Medicine
2011English

Optimal Mode of Clearance in Critically Ill Patients With Acute Kidney Injury (OMAKI) - A Pilot Randomized Controlled Trial of Hemofiltration Versus Hemodialysis: A Canadian Critical Care Trials Group Project

Critical Care
Critical CareIntensive Care Medicine
2012English

Acute Kidney Injury Among Critically Ill Patients With Pandemic H1N1 Influenza a in Canada: Cohort Study

BMC Nephrology
Nephrology
2013English

Physical Methods for the Treatment of Fever in Critically Ill Patients: A Randomized Controlled Trial

Revista da Escola de Enfermagem da U S P
Nursing
2016English

Care of the Critically Ill Emergency Department Patient With Acute Kidney Injury

Emergency Medicine International
Emergency Medicine
2012English

Fluid Balance and Mortality in Critically Ill Patients With Acute Kidney Injury: A Multicenter Prospective Epidemiological Study

Critical Care
Critical CareIntensive Care Medicine
2015English

Erythropoietin in Traumatic Brain Injury Associated Acute Kidney Injury: A Randomized Controlled Trial

Acta Anaesthesiologica Scandinavica
MedicineAnesthesiologyPain Medicine
2018English

Plasma Neutrophil Gelatinase-Associated Lipocalin Is an Early Marker of Acute Kidney Injury in Critically Ill Patients: A Prospective Study

Critical Care
Critical CareIntensive Care Medicine
2009English

Neutrophil Gelatinase-Associated Lipocalin Predicts Acute Kidney Injury in Critically Ill Patients

Critical Care
Critical CareIntensive Care Medicine
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy